European Journal of Rheumatology
Search Results
Total of 5 results
Ranking
Release Date Sort Sort Article Type

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Döndü Üsküdar Cansu, Sabri Güncan, N. Şule Yaşar Bilge, Timuçin Kaşifoğlu, Cengiz Korkmaz

(Eur J Rheumatol 2014; 1: 62-66) DOI: 10.5152/eurjrheumatol.2014.019

Abstract Full Text (PDF) Related Articles

Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis

Kathleen Tymms, Belinda Butcher, Tegan Smith, Geoffrey Littlejohn, OPAL Consortium

(Eur J Rheumatol 2021; 8: 67-72) DOI: 10.5152/eurjrheum.2020.20024

Abstract Full Text (PDF) Related Articles

Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm

Akash Gupta, Yuliya Afinogenova, Nikolai A. Podoltsev, Abhijeet Danve

(Eur J Rheumatol 2022; 9: 215-216) DOI: 10.5152/eurjrheum.2022.21097

Abstract Full Text (PDF) Related Articles
EISSN 2148-4279